Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
deals
2
×
life sciences
national blog main
azacitidine
bayer
beta-thalassemia
clinical trials
cronos group
dacogen
decitabine
dna
epigenetics
epizyme
farydak
flagship pioneering
fulcrum therapeutics
ginkgo bioworks
hyperammonemia
insulated genomic domains
james collins
kaleido biosciences
liver diseases
mahesh karande
national top stories
neurological diseases
new york blog main
new york top stories
omega therapeutics
panobinostat
phenylketonuria
richard young
robert gould
rudolf jaenisch
san francisco blog main
san francisco top stories
sickle cell disease
What
called
2
×
medicines
2
×
aims
approach
bacteria
based
biology
biotech
bioworks
company
comprised
debuts
developer
developing
drugs
engineered
epigenetic
epigenetics
field
flagship’s
ginkgo
lands
living
morning
new
omega
ramp
research
startup
step
synlogic
synthetic
teaming
therapeutics
touting
Language
unset
Current search:
called
×
deals
×
medicines
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
